39 related articles for article (PubMed ID: 12593531)
1. Adenosine Receptor Subtypes and Cardioprotection.
Lee JE; Wilcox K; Jacobson KA; Dichter M; Liang BT
Drug Dev Res; 1998; 45(3-4):394-401. PubMed ID: 38234711
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A
Hanif A; Agba SO; Ledent C; Tilley SL; Morisseau C; Nayeem MA
Mol Cell Biochem; 2021 May; 476(5):1965-1978. PubMed ID: 33511551
[TBL] [Abstract][Full Text] [Related]
3. Drug Delivery and Nanoformulations for the Cardiovascular System.
Geldenhuys WJ; Khayat MT; Yun J; Nayeem MA
Res Rev Drug Deliv; 2017 Feb; 1(1):32-40. PubMed ID: 28713881
[TBL] [Abstract][Full Text] [Related]
4. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
Geldenhuys WJ; Hanif A; Yun J; Nayeem MA
Molecules; 2017 Jun; 22(6):. PubMed ID: 28587166
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
[TBL] [Abstract][Full Text] [Related]
6. Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase.
Nayeem MA; Zeldin DC; Boegehold MA; Morisseau C; Marowsky A; Ponnoth DS; Roush KP; Falck JR
Am J Physiol Regul Integr Comp Physiol; 2010 Jul; 299(1):R325-33. PubMed ID: 20427718
[TBL] [Abstract][Full Text] [Related]
7. High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases.
Nayeem MA; Ponnoth DS; Boegehold MA; Zeldin DC; Falck JR; Mustafa SJ
Am J Physiol Regul Integr Comp Physiol; 2009 Mar; 296(3):R567-74. PubMed ID: 19109366
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice.
Nayeem MA; Poloyac SM; Falck JR; Zeldin DC; Ledent C; Ponnoth DS; Ansari HR; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2068-78. PubMed ID: 18805895
[TBL] [Abstract][Full Text] [Related]
9. ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.
Duflot S; Riera B; Fernández-Veledo S; Casadó V; Norman RI; Casado FJ; Lluís C; Franco R; Pastor-Anglada M
Mol Cell Biol; 2004 Apr; 24(7):2710-9. PubMed ID: 15024061
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide in ischemic preconditioning.
Pagliaro P; Gattullo D; Rastaldo R; Losano G
Ital Heart J; 2001 Sep; 2(9):660-8. PubMed ID: 11666094
[TBL] [Abstract][Full Text] [Related]
11. [The role of adenosine in "ischemic preconditioning"].
Schaper W; Vogt A; Htun P
Z Kardiol; 1996; 85 Suppl 6():185-90. PubMed ID: 9064964
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells.
Nayeem MA; Mustafa SJ
Pol J Pharmacol; 2002; 54(5):443-53. PubMed ID: 12593531
[TBL] [Abstract][Full Text] [Related]
13. Sublethal simulated ischemia promotes delayed resistance against ischemia via ATP-sensitive (K+) channels in murine myocytes: role of PKC and iNOS.
Nayeem MA
Antioxid Redox Signal; 2004 Apr; 6(2):375-83. PubMed ID: 15025939
[TBL] [Abstract][Full Text] [Related]
14. Ischemic and pharmacological induction of delayed cellular protection in iNOS gene-disrupted mice myocytes.
Nayeem MA; Mustafa SJ
Pol J Pharmacol; 2003; 55(1):73-9. PubMed ID: 12856829
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]